Potency of descending pain modulatory system is linked with peripheral sensory dysfunction in fibromyalgia: An exploratory study.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
18
1
2019
pubmed:
18
1
2019
medline:
31
1
2019
Statut:
ppublish
Résumé
Fibromyalgia (FM) is characterized by chronic widespread pain whose pathophysiological mechanism is related to central and peripheral nervous system dysfunction. Neuropathy of small nerve fibers has been implicated due to related pain descriptors, psychophysical pain, and neurophysiological testing, as well as skin biopsy studies. Nevertheless, this alteration alone has not been previously associated to the dysfunction in the descending pain modulatory system (DPMS) that is observed in FM. We hypothesize that they associated, thus, we conducted a cross-sectional exploratory study.To explore small fiber dysfunction using quantitative sensory testing (QST) is associated with the DPMS and other surrogates of nociceptive pathways alterations in FM.We run a cross-sectional study and recruited 41 women with FM, and 28 healthy female volunteers. We used the QST to measure the thermal heat threshold (HTT), heat pain threshold (HPT), heat pain tolerance (HPT), heat pain tolerance (HPTo), and conditional pain modulation task (CPM-task). Algometry was used to determine the pain pressure threshold (PPT). Scales to assess catastrophizing, anxiety, depression, and sleep disturbances were also applied. Serum brain-derived neurotrophic factor (BDNF) was measured as a marker of neuroplasticity. We run multivariate linear regression models by group to study their relationships.Samples differed in their psychophysical profile, where FM presented lower sensitivity and pain thresholds. In FM but not in the healthy subjects, regression models revealed that serum BDNF was related to HTT and CPM-Task (Hotelling Trace = 1.80, P < .001, power = 0.94, R = 0.64). HTT was directly related to CPM-Task (B = 0.98, P = .004, partial-η = 0.25), and to HPT (B = 1.61, P = .008, partial η = 0.21), but not to PPT. Meanwhile, BDNF relationship to CPM-Task was inverse (B = -0.04, P = .043, partial-η = 0.12), and to HPT was direct (B = -0.08, P = .03, partial-η = 0.14).These findings high spot that in FM the disinhibition of the DPMS is positively correlated with the dysfunction in peripheral sensory neurons assessed by QST and conversely with serum BDNF.
Identifiants
pubmed: 30653087
doi: 10.1097/MD.0000000000013477
pii: 00005792-201901180-00002
pmc: PMC6370006
doi:
Substances chimiques
Brain-Derived Neurotrophic Factor
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13477Références
J Psychiatr Res. 2011 Aug;45(8):995-1004
pubmed: 21550050
Neuron. 2006 Oct 5;52(1):77-92
pubmed: 17015228
Pain Med. 2012 Nov;13(11):1425-35
pubmed: 23036076
JAMA. 2014 Apr 16;311(15):1547-55
pubmed: 24737367
Clin Neurophysiol. 2001 Oct;112(10):1881-7
pubmed: 11595147
Brain Res. 2002 Dec 27;958(2):338-46
pubmed: 12470870
Arthritis Rheum. 2003 May;48(5):1420-9
pubmed: 12746916
J Psychiatr Res. 2007 Oct;41(7):600-5
pubmed: 16600301
BMC Neurol. 2011 May 25;11:55
pubmed: 21612589
J Pain. 2009 Sep;10(9):969-75
pubmed: 19464960
Curr Opin Anaesthesiol. 2010 Oct;23(5):611-5
pubmed: 20543676
J Psychosom Res. 2010 Mar;68(3):223-33
pubmed: 20159207
Trends Pharmacol Sci. 2003 Mar;24(3):116-21
pubmed: 12628355
J Pain. 2007 Nov;8(11):893-901
pubmed: 17681887
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8107-12
pubmed: 11438749
Sci Rep. 2018 Aug 20;8(1):12477
pubmed: 30127510
J Neurosci. 2008 Apr 23;28(17):4533-40
pubmed: 18434532
J Rheumatol. 2016 Sep;43(9):1743-8
pubmed: 27370877
J Neurosci. 2001 Jun 15;21(12):4469-77
pubmed: 11404434
Pain. 2010 Jun;149(3):495-500
pubmed: 20356675
J Clin Sleep Med. 2008 Dec 15;4(6):563-71
pubmed: 19110886
CNS Drugs. 2012 Apr 1;26(4):297-307
pubmed: 22452526
Muscle Nerve. 2009 Apr;39(4):529-35
pubmed: 19260066
Clin J Pain. 2011 Oct;27(8):682-90
pubmed: 21487289
Nature. 2005 Dec 15;438(7070):1017-21
pubmed: 16355225
Curr Rheumatol Rep. 2002 Aug;4(4):299-305
pubmed: 12126581
Rheum Dis Clin North Am. 2009 May;35(2):263-74
pubmed: 19647141
Clin Neurophysiol. 2008 Aug;119(8):1703-1704
pubmed: 18490194
Medicine (Baltimore). 2016 Apr;95(17):e3353
pubmed: 27124022
BMC Pharmacol Toxicol. 2014 Jul 23;15:40
pubmed: 25052847
Arq Neuropsiquiatr. 2011 Dec;69(6):943-8
pubmed: 22297885
Pain. 2012 Mar;153(3):602-618
pubmed: 22192712
Front Hum Neurosci. 2016 Jun 27;10:308
pubmed: 27445748
Support Care Cancer. 2012 Feb;20(2):319-24
pubmed: 21243377
Trends Neurosci. 2005 Feb;28(2):101-7
pubmed: 15667933
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
Mol Pharmacol. 2013 Oct;84(4):511-20
pubmed: 23847084
Neuroscience. 2016 Dec 3;338:114-129
pubmed: 27291641
Front Hum Neurosci. 2016 Jul 15;10:357
pubmed: 27471458
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Apr;27(2):228-31
pubmed: 15960271
Neurology. 2003 Feb 11;60(3):465-70
pubmed: 12578928
Curr Opin Support Palliat Care. 2014 Jun;8(2):143-51
pubmed: 24752199
Pain. 1994 Aug;58(2):185-193
pubmed: 7816486
Braz J Psychiatry. 2012 Dec;34(4):389-94
pubmed: 23429809
J Neurosci. 2002 Aug 1;22(15):6724-31
pubmed: 12151551
Growth Factors. 2004 Sep;22(3):123-31
pubmed: 15518235
J Neurosci. 1999 Jun 15;19(12):5138-48
pubmed: 10366647
Pain. 2003 Oct;105(3):403-413
pubmed: 14527701
Clin J Pain. 2001 Dec;17(4):316-22
pubmed: 11783811
PLoS One. 2015 Sep 17;10(9):e0138024
pubmed: 26379048
Pain. 2007 Jul;130(1-2):177-87
pubmed: 17459587